BUGWORKS RESEARCH
BUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR). The company was founded in 2014 and is based in Bangalore, India.
BUGWORKS RESEARCH
Industry:
Biotechnology Health Care Life Science Pharmaceutical Product Research
Founded:
2014-02-04
Address:
Bangalore, Karnataka, India
Country:
India
Website Url:
http://www.bugworksresearch.com
Total Employee:
11+
Status:
Active
Contact:
+91-8296582662
Total Funding:
36.11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Current Advisors List
Board_member
Board_member
Board_member
Board_observer
Board_member
Board_member
Current Employees Featured
Bala Subramanian Co-Founder & COO @ BUGWORKS Research
Co-Founder & COO
Anand Anandkumar Founder and CEO @ BUGWORKS Research
Founder and CEO
2014-02-01
Santanu Datta Chief Scientific Officer & Executive Director @ BUGWORKS Research
Chief Scientific Officer & Executive Director
Founder
Investors List
3one4 Capital
3one4 Capital investment in Series B - BUGWORKS Research
IM Holdings BV
IM Holdings BV investment in Series B - BUGWORKS Research
Acquipharma
Acquipharma investment in Series B - BUGWORKS Research
Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw investment in Series B - BUGWORKS Research
Lord Jim O'Neill
Lord Jim O'Neill investment in Series B - BUGWORKS Research
Featherlite
Featherlite investment in Series B - BUGWORKS Research
Global Brain Corporation
Global Brain Corporation investment in Series B - BUGWORKS Research
Lightrock
Lightrock investment in Series B - BUGWORKS Research
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Series B - BUGWORKS Research
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Series B - BUGWORKS Research
Official Site Inspections
http://www.bugworksresearch.com Semrush global rank: 2.83 M Semrush visits lastest month: 5.73 K
- Host name: 104.21.57.68
- IP address: 104.21.57.68
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BUGWORKS Research"
About Us - Bugworks
About Us Inventive thinkers with a unified goal of solving global health challenges Our Journey Headquartered in the USA with subsidiaries in India and AustraliSee details»
Novel broad-spectrum antibiotic compound - GARDP
Jun 11, 2024 The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human …See details»
Bugworks Research Inc. | LinkedIn
Bugworks is a proud partner among 49 global organisations to support the Supporting Innovative Global Health Technologies (SIGHT) Act, a legislation to empower the United States Agency for ...See details»
BUGWORKS Research - Crunchbase Company Profile
Contact Email info@bugworksresearch.com Phone Number +91-8296582662 BUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR).See details»
GARDP and Bugworks join forces to accelerate development of a …
Jul 28, 2023 Geneva and Bangalore, 27 July 2023 – The Global Antibiotic Research & Development Partnership (GARDP) is joining forces with Bugworks Research Inc. (Bugworks), …See details»
Bugworks Research Inc. | LinkedIn
Bugworks Research Inc. | 8,002 followers on LinkedIn. Path breaking solutions to large unmet needs in Antimicrobial resistance (AMR) and immuno-oncology. | Path breaking solutions to large unmet needs in Antimicrobial resistance …See details»
Bugworks Research Inc. | LinkedIn
Bugworks was awarded the best poster at the ongoing "ESMO Targeted Anticancer Therapies Congress 2024" in Paris (26-28 February 2024) Bugworks Research Inc., along with Cytecare …See details»
Our Story - Bugworks
We are proud of our ongoing commitment to the research and development of new antibacterial agents and anti-cancer treatments, and we are working hard to ensure that both individual …See details»
Bugworks Research - PitchBook
Bugworks Research General Information Description. Developer of a novel class of antibiotic drugs designed to tackle the problem of antimicrobial resistance. The company's platform …See details»
Our Team - Bugworks
Abraham currently manages the TCD Group of companies which includes a Contract Research Organization, Health Economics and Outcomes Research business and a Software …See details»
Bugworks Research - Craft
Bugworks Research has 5 employees across 3 locations and $16.5 m in total funding,. See insights on Bugworks Research including office locations, competitors, revenue, financials, …See details»
Bugworks - Carb-X
Jul 1, 2017 BUGWORKS Delaware, USA & Bangalore, India bugworksresearch.com. GYROX GYRASE-TOPOISOMERASE INHIBITOR. Direct-Acting Small Molecule Therapeutic In …See details»
Bugworks Raises US$7.5M From a Global Investment Syndicate to …
Apr 23, 2020 BANGALORE, India; WILMINGTON, Delaware and ADELAIDE, Australia, April 23, 2020 /PRNewswire/ -- Bugworks Research Inc, a global biopharma start-up designing novel …See details»
Bugworks secures funding from US Government's Defense Threat …
Apr 26, 2021 About Bugworks (www.bugworksresearch.com) Bugworks, a Delaware, Bangalore and Adelaide based biotech innovator is at the forefront of the scientific innovation to deliver …See details»
Bugworks Research Inc. and Cytecare Cancer Hospitals announce ...
Sep 19, 2022 About Bugworks Research (www.bugworksresearch.com) Bugworks Research is a clinical-stage biopharmaceutical company, developing novel therapeutic assets to combat …See details»
Our Science – Bugworks
Our Science At the forefront of designing novel therapeutic assets using innovative science Our Platform Global Ecosystem of CRO & University Partners (ExecutioSee details»
Bugworks secures funding from US Government's Defense Threat …
Apr 26, 2021 WASHINGTON, LONDON and TOKYO, April 26, 2021 /PRNewswire/ -- Bugworks Research, Inc ("Bugworks"), secures funding from the Defense Threat Reduction Agency …See details»
News – Bugworks
June 11, 2024 Published in bugworksresearch.com. Bugworks has recently been featured in the Times of India, highlighting the global impact of antimicrobial resistance (AMR) and the …See details»
Working At Bugworks Research: Company Overview and Culture
Find out what it's like to work at Bugworks Research. See what kind of people work at Bugworks Research, career paths working at Bugworks Research, company culture, salaries, employee …See details»